Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (411-420 of 544) with videos related to

Pageof 55
Sort By:
Human Vaccines & Immunotherapeutics|April 11, 2013
Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccineScott A Halperin, Brian J Ward, Marc Dionne, et al.
Vaccine|October 4, 2005
Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adultsScott A Halperin, Simon Dobson, Shelly McNeil, et al.
Vaccine|October 19, 2006
An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccineJoanne M Langley, Gerald Predy, R Guasparini, et al.
Vaccine|December 20, 2011
The changing and dynamic epidemiology of meningococcal diseaseScott A Halperin, Julie A Bettinger, Brian Greenwood, et al.
Vaccine|December 3, 2014
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trialJoanne M Langley, Louise Frenette, Robert Jeanfreau, et al.
Vaccine|June 23, 2009
A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunityJason Kindrachuk, Håvard Jenssen, Melissa Elliott, et al.
Diabetes Care|January 26, 2021
Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 DiabetesClaire L Meek, Diana Tundidor, Denice S Feig, et al.
The Pediatric Infectious Disease Journal|December 19, 2013
Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccineScott A Halperin, Bruce Tapiéro, Marc Dionne, et al.
Human Vaccines & Immunotherapeutics|February 12, 2016
Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, CanadaJennifer E Isenor, Tania A Alia, Jessica L Killen, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Side chain-to-side chain cyclization by intramolecular click reaction--building blocks, solid phase synthesis and conformational characterizationSonia Cantel, Jose A Halperin, Michael Chorev, et al.
Pageof 55

Showing results (411-420 of 544) with videos related to

Sort By:
Pageof 55
Human Vaccines & Immunotherapeutics|April 11, 2013
Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccineScott A Halperin, Brian J Ward, Marc Dionne, et al.
Vaccine|October 4, 2005
Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adultsScott A Halperin, Simon Dobson, Shelly McNeil, et al.
Vaccine|October 19, 2006
An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccineJoanne M Langley, Gerald Predy, R Guasparini, et al.
Vaccine|December 20, 2011
The changing and dynamic epidemiology of meningococcal diseaseScott A Halperin, Julie A Bettinger, Brian Greenwood, et al.
Vaccine|December 3, 2014
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trialJoanne M Langley, Louise Frenette, Robert Jeanfreau, et al.
Vaccine|June 23, 2009
A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunityJason Kindrachuk, Håvard Jenssen, Melissa Elliott, et al.
Diabetes Care|January 26, 2021
Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 DiabetesClaire L Meek, Diana Tundidor, Denice S Feig, et al.
The Pediatric Infectious Disease Journal|December 19, 2013
Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccineScott A Halperin, Bruce Tapiéro, Marc Dionne, et al.
Human Vaccines & Immunotherapeutics|February 12, 2016
Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, CanadaJennifer E Isenor, Tania A Alia, Jessica L Killen, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Side chain-to-side chain cyclization by intramolecular click reaction--building blocks, solid phase synthesis and conformational characterizationSonia Cantel, Jose A Halperin, Michael Chorev, et al.
Pageof 55